FDA: more Inspections in 2014
Recommendation

2/3 September 2026
Copenhagen, Denmark
When “Human Error” isn’t enough: Successful Failure Investigation
U.S. President Barack Obama has signed the budget for the fiscal 2014 for U.S. Government agencies. With their new budget, The U.S Food and Drug Administration FDA will be able to increase drug plant inspections worldwide and especially in China. The FDA has been given the money which was needed to fund necessary operations. And it seems they got what they requested. In their request, FDA asked for budget to "perform additional foreign inspections in China, focusing on facilities that produce drugs and drug ingredients ...". "FDA will also conduct training with Chinese drug authorities to enhance their ability to regulate pharmaceutical products exported to the United States".
Related GMP News
01.07.2026Should TGA publish GMP Certificates?
24.06.2026Quality Unit (QU) in the Focus of a Warning Letter: Oversight Failures and FDA Expectations
03.06.2026GMP Auditor Association Developments January through April 2026
20.05.2026CAPA and Root Cause Analysis - why FDA keeps calling them out
20.05.2026FDA Pilots One-Day Inspectional Assessments to Expand Oversight


